Medications

Pharma giant Pfizer to raise some drug prices

Pfizer said Friday it would raise US prices on 41 drugs in January, reversing a price freeze implemented over the summer in the face of criticism by President Donald Trump.

Medical economics

Brand drug discount cards increase private insurer costs by 46%

Discount cards for brand-name drugs provided to patients increased private insurer costs by 46% and varied in their impact on out-of-pocket payments by patients, found new research in CMAJ (Canadian Medical Association Journal).

Health

Out-of-pocket costs similar for infliximab, infliximab-dyyb

(HealthDay)—Under Medicare Part D, out-of-pocket costs are similar for infliximab and its biosimilar infliximab-dyyb, according to a research letter published in the Sept. 4 issue of the Journal of the American Medical ...

page 1 from 2